Clinical Trials List
2021-10-18 - 2026-11-22
Phase III
Not yet recruiting5
Recruiting3
ICD-10Z85.038
Personal history of other malignant neoplasm of large intestine
ICD-9V10.05
Personal history of malignant neoplasm of large intestine
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 黃敬文 Division of Colorectal Surgery
- 蔡祥麟 Division of Colorectal Surgery
- 張琮琨
- Wei-Chih Su Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chiun Hsu 未分科
- 張端瑩 Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- Ann-Lii Cheng 未分科
- Ying-Chun Shen Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 楊明翰 Division of Hematology & Oncology
- 林宗哲 未分科
- YU-YUN SHAO Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- Been Ren Lin Division of Hematology & Oncology
- Chih-Hung Hsu 未分科
- TA-CHEN HUANG Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin 未分科
- 張伸吉 未分科
- 謝明皓 未分科
- 陳宏彰 未分科
- 蔡元耀 未分科
- Tao-Wei Ke 未分科
- 陳奕彰 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsai-Sheng Yang 未分科
- Mengting Peng Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- Jen-Shi Chen Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Peng-Chan Lin 未分科
- 蘇勇曄 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 黃盈慈 Division of Hematology & Oncology
- 陳柏全 Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Po-Wen Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Po-Li Wei 未分科
- Huey-En Tzeng 未分科
- 郭立人 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yee Chao 未分科
- Rheun-Chuan Lee Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Yi-Ping Hung 未分科
- Ming-Huang Chen 未分科
- Chien-An Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
755 participants
